Velmurugan, Bharath K <br/><br/>
PP2A deactivation is a common event in oral cancer and reactivation by FTY720 shows promising therapeutic potential.  [electronic resource] 

 -  Journal of cellular physiology  Feb 2018 
 - 1300-1311 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1097-4652 
<br/><br/><label>Standard No.: </label>10.1002/jcp.26001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--pharmacology<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Dose-Response Relationship, Drug<br/>Enzyme Activation<br/>Enzyme Activators--pharmacology<br/>Female<br/>Fingolimod Hydrochloride--pharmacology<br/>Glycogen Synthase Kinase 3 beta--metabolism<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Kaplan-Meier Estimate<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Mouth Neoplasms--drug therapy<br/>Multivariate Analysis<br/>Neoplasm Staging<br/>Odds Ratio<br/>Phosphorylation<br/>Proportional Hazards Models<br/>Protein Phosphatase 2--metabolism<br/>Risk Factors<br/>Signal Transduction--drug effects<br/>Squamous Cell Carcinoma of Head and Neck<br/>Time Factors<br/>Tyrosine